ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid
CAS No. 55483-24-4
ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid( —— )
Catalog No. M31919 CAS No. 55483-24-4
ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 630 | In Stock |
|
50MG | Get Quote | In Stock |
|
100MG | Get Quote | In Stock |
|
Biological Information
-
Product Nameent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid
-
NoteResearch use only, not for human use.
-
Brief Descriptionent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.
-
Descriptionent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55483-24-4
-
Formula Weight334.5
-
Molecular FormulaC20H30O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
1,7-Diphenyl-5-hydro...
1,7-Diphenyl-5-hydroxy-4,6-hepten-3-one is a natural product of Alpinia, Zingiberaceae. 1,7-Diphenyl-5-hydroxy-4,6-hepten-3-one can be used as a reference standard.
-
NVP-ACC789
ACC-789 (NVP-ACC789; ZK-202650) is an effective, specific and orally active inhibitor of the VEGF receptor tyrosine kinases.
-
Epitinib succinate
Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer.